Article
Decreased A20 mRNA and protein expression in peripheral blood mononuclear cells in patients with type 2 diabetes and latent autoimmune diabetes in adults.
Diabetes research and clinical practice - 1 Dec 2014
Cheng Liqing, Zhang Dongmei, Jiang Youzhao, Deng Wuquan, Wu Qi'nan, Jiang Xiaoyan, Chen Bing
Abstract excerpt
AIMS: A20 is a negative regulator of nuclear factor kappa B activation and the central gatekeeper in inflammation and immunity. While its role in type 1 diabetes has been widely studied, its expression level in immune cells from type 2 diabetes (T2D) and latent autoimmune diabetes in adult (LADA) patients remains unclear. This study aimed to clarify whether the expression of A20 is altered in patients with T2D or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
